C0243095||Antithrombotic activity
C4278231||Batroxase
C0025543||metalloprotease
C4033446||Bothrops atrox venom
C0599779||model
C0042487||venous thrombosis
C0037380||Snake venoms
C3161035||models
C0013227||drugs
C0040549||Toxins
C0005779||hemostasis
C2603343||study
C0243095||antithrombotic activity
C4278231||Batroxase
C0025543||P-I metalloprotease
C4033446||Bothrops atrox venom
C0599779||animal model
C0042487||venous thrombosis
C0243095||antithrombotic activity
C4278231||Batroxase
C1515655||in vivo
C0599779||model
C0282574||Virchow's Triad
C0232338||blood flow
C0333183||partial stenosis
C0042458||inferior vena cava
C0229962||vessel wall
C0178314||injury
C0060229||ferric chloride
C0037513||sodium heparin
C0550585||Bleeding
C2266672||clotting time
C0019080||bleeding assay
C1148560||immunogenicity
C4278231||Batroxase
C4278231||Batroxase
C0243095||thrombus formation
C0019134||heparin
C4278231||Batroxase
C0019134||heparin
C0550585||bleeding
C2266672||clotting time
C0020971||Immunizations
C3887509||rabbits
C4278231||Batroxase
C0003241||antibodies
C0025543||metalloprotease
C4278231||Batroxase
C0243095||antithrombotic activity
C1515655||in vivo
C1148560||immunogenicity
C0012634||thrombogenic disorders